A Phase 2b, Randomized, Double-Blind, Saline Placebo- and Active-Controlled, Multicenter Study of HTX-011 Via Infiltration for Postoperative Analgesia in Subjects Undergoing Total Knee Arthroplasty
Latest Information Update: 29 Oct 2021
At a glance
- Drugs Bupivacaine/meloxicam (Primary) ; Bupivacaine; Ropivacaine
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Heron Therapeutics
- 05 Oct 2020 Results of pooled analysis of data pooled from 4 studies assessing the safety and plasma concentrations of various doses of HTX-011 in a variety of surgical sites with differing vascularity, presented at the ANESTHESIOLOGY 2020 Annual Meeting of the American Society of Anesthesiologists
- 04 Jun 2020 According to the Heron Therapeutics media release, data from this study was published published online by The Journal of Arthroplasty.
- 04 Jun 2020 Results published in the Heron Therapeutics media release